EXTENDICARE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.43 CAD | +0.95% |
|
-.--% | +2.06% |
| 05-23 | Extendicare Inc. Announces Alan Hibben Not Been Re-Elected as A Director | CI |
| 05-21 | Extendicare Price Target Raised to $8.50 at RBC | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 1.43B 1.05B 82.51B | Sales 2025 * | 1.44B 1.06B 83.06B | Capitalization | 620M 455M 35.7B |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.43 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.43 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 23,500 |
| Yield 2024 * |
6.46% | Yield 2025 * |
10.9% | Free-Float | 86.08% |
More Fundamentals
* Assessed data
More news
Latest transcript on Extendicare Inc.
More recommendations
More press releases
| 1 day | +0.95% | ||
| 1 month | +0.27% | ||
| 3 months | +8.31% | ||
| 6 months | +4.94% | ||
| Current year | +2.06% |
1 week
7.28
7.53
1 month
7.208.04
Current year
6.638.04
1 year
5.758.04
3 years
5.758.71
5 years
4.909.60
10 years
4.9010.75
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 11/03/18 | |
David Bacon
DFI | Director of Finance/CFO | - | 31/03/19 |
| Chief Tech/Sci/R&D Officer | - | 31/08/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Aladin Mawani
BRD | Director/Board Member | 72 | 30/11/17 |
Alvin Libin
BRD | Director/Board Member | - | 19/01/84 |
| Director/Board Member | - | 22/02/95 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.25% | 11 M€ | -.--% | ||
| 0.04% | 1 M€ | -.--% | - | |
| 0.00% | 746 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/05/24 | 7.43 | +0.41% | 161,014 |
| 30/05/24 | 7.4 | +0.54% | 87,798 |
| 29/05/24 | 7.36 | -0.67% | 79,468 |
| 28/05/24 | 7.41 | -1.72% | 118,703 |
| 27/05/24 | 7.54 | +1.48% | 34,719 |
Delayed Quote Toronto S.E., May 31, 2024 at 09:00 pm
More quotes
Extendicare Inc. is a provider of care and services for seniors across Canada. The Company operates under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The Company operates through four segments: Long-term Care, Home Health Care, Managed Services and Corporate. Its Long-term Care segment includes over 53 long-term care homes, which it owns and operates in Canada. Its Home Health Care segment operates through its subsidiary, ParaMed, which provides complex nursing care, occupational, physical and speech therapy, and assistance with daily activities. Its Managed Services segment includes its management, consulting and group purchasing divisions. Through the Extendicare Assist division, it provides management and consulting services to third parties, and through the SGP Purchasing Partner Network division, it offers purchasing contracts to other senior care providers for food, capital equipment, furnishings, cleaning, nursing supplies, and more.
Calendar
14/08/2024
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
7.43
CAD
Average target price
8.333
CAD
Spread / Average Target
+12.16%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +2.06% | 454M | |
| +25.52% | 88.99B | |
| -24.52% | 74.82B | |
| +0.49% | 25.03B | |
| +4.31% | 17.88B | |
| -14.25% | 16.43B | |
| +2.97% | 15.77B | |
| +79.20% | 13.21B | |
| +70.11% | 13.08B | |
| +40.44% | 12.9B |
- Stock Market
- Equities
- EXE Stock
